Geographic · Operating Income

EMEA — Operating Income

Zimmer Biomet Holdings EMEA — Operating Income decreased by 8.4% to $152.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.1%, from $150.50M to $152.20M. Over 4 years (FY 2021 to FY 2025), EMEA — Operating Income shows an upward trend with a 10.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Rolls up toOperating Income

How to read this metric

Higher operating income indicates strong regional profitability and effective cost management.

Detailed definition

The profit or loss generated by the EMEA segment after deducting cost of goods sold and operating expenses from total re...

Peer comparison

The primary metric for comparing regional performance and profitability across the medical device industry.

Metric ID: zbh_segment_emea_operating_income_loss

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$91.90M$86.90M$144.90M$104.90M$104.30M$85.80M$115.10M$149.50M$132.00M$101.00M$162.50M$154.80M$151.60M$123.80M$164.10M$150.50M$158.50M$121.80M$166.10M$152.20M
QoQ Change-5.4%+66.7%-27.6%-0.6%-17.7%+34.1%+29.9%-11.7%-23.5%+60.9%-4.7%-2.1%-18.3%+32.6%-8.3%+5.3%-23.2%+36.4%-8.4%
YoY Change+13.5%-1.3%-20.6%+42.5%+26.6%+17.7%+41.2%+3.5%+14.8%+22.6%+1.0%-2.8%+4.6%-1.6%+1.2%+1.1%
Range$85.80M$166.10M
CAGR+11.2%
Avg YoY Growth+10.3%
Median YoY Growth+4.0%

Frequently Asked Questions

What is Zimmer Biomet Holdings's emea — operating income?
Zimmer Biomet Holdings (ZBH) reported emea — operating income of $152.20M in Q1 2026.
How has Zimmer Biomet Holdings's emea — operating income changed year-over-year?
Zimmer Biomet Holdings's emea — operating income increased by 1.1% year-over-year, from $150.50M to $152.20M.
What is the long-term trend for Zimmer Biomet Holdings's emea — operating income?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's emea — operating income has grown at a 10.1% compound annual growth rate (CAGR), from $405.90M to $596.90M.
What does emea — operating income mean?
The operating profit or loss for the EMEA business segment.